Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 139.21%562.63M | 99.84%550.59M | 1.64%406.28M | -14.37%1.25B | -36.04%334.21M | -31.99%235.21M | -2.24%275.51M | 30.07%399.72M | 60.99%1.46B | 73.60%522.5M |
| Cost of revenue | 161.51%483.72M | 127.37%498.71M | 10.67%357.18M | -22.08%998.08M | -36.26%285.13M | -41.68%184.97M | -8.71%219.34M | 16.89%322.74M | 37.02%1.28B | 57.35%447.32M |
| Gross profit | 57.09%78.91M | -7.65%51.88M | -36.22%49.1M | 41.48%249.9M | -34.73%49.07M | 75.19%50.24M | 35.14%56.17M | 146.69%76.98M | 699.23%176.63M | 350.08%75.18M |
| Operating expense | 401.59%22.73M | -26.92%24.93M | -45.80%25.38M | 120.95%207.1M | 2,260.54%64.14M | -87.51%4.53M | 76.87%34.11M | 255.28%46.83M | -19.39%93.73M | 701.47%2.72M |
| Selling and administrative expenses | ---- | ---- | ---- | 74.81%225.9M | ---- | ---- | ---- | ---- | -8.61%129.23M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 74.81%225.9M | ---- | ---- | ---- | ---- | -8.61%129.23M | ---- |
| Other operating expenses | -12.37%31.14M | -54.01%25.89M | -18.61%45.63M | 51.77%196.13M | 350.68%64.14M | -14.33%35.54M | 44.38%56.3M | 62.41%56.06M | --129.23M | --14.23M |
| Total other operating income | -72.88%8.41M | -95.64%967K | 119.34%20.25M | -47.05%18.79M | ---- | 495.22%31.01M | 12.60%22.2M | -56.74%9.23M | 41.28%35.49M | 828.55%11.51M |
| Operating profit | 22.92%56.18M | 22.13%26.95M | -21.34%23.71M | -48.37%42.8M | -120.79%-15.06M | 701.67%45.7M | -0.97%22.07M | 67.27%30.15M | 156.87%82.89M | 342.80%72.47M |
| Net non-operating interest income (expenses) | 73.06%-9.92M | 45.19%-9.46M | 47.07%-12M | 53.37%-42.11M | 159.27%21.07M | -84.72%-36.82M | 12.44%-17.26M | -49.92%-22.67M | -53.19%-90.32M | -36.94%-35.54M |
| Non-operating interest income | 34.44%121K | ---- | 266.04%1.76M | 70.67%2.56M | 3,716.49%21.07M | -84.10%90K | 183.33%272K | 67.83%480K | 148.76%1.5M | 538.10%552K |
| Non-operating interest expense | -72.80%10.04M | -46.04%9.46M | -40.58%13.76M | -51.35%44.67M | ---- | 80.06%36.91M | -11.49%17.54M | 50.25%23.15M | 54.16%91.82M | 39.74%36.09M |
| Net investment income | 27.62M | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -104.27%-951K | 113.75%22.28M | ||||||||
| Less:Other special charges | ---- | ---- | ---- | -246.67%-3.28M | ---- | ---- | ---- | ---- | -59.16%-947K | ---- |
| Less:Write off | ---- | ---- | ---- | 119.85%4.23M | ---- | ---- | ---- | ---- | -113.11%-21.33M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 420.78%46.26M | 264.11%17.49M | 56.74%11.71M | 84.08%27.35M | -83.74%6.01M | 132.27%8.88M | 87.11%4.8M | 157.78%7.47M | 104.05%14.86M | 121.51%36.92M |
| Income tax | -15.73%5.6M | 36.53%5.97M | 57.37%4.71M | 4,418.49%10.75M | 38.61%-3.84M | 100.60%6.64M | 155.55%4.38M | 103.89%2.99M | 201.27%238K | -164.92%-6.25M |
| Net income | 1,714.55%40.66M | 2,590.42%11.52M | 56.31%7.01M | 13.53%16.6M | -77.20%9.84M | 107.27%2.24M | -49.94%428K | 212.99%4.48M | 103.99%14.62M | 125.50%43.18M |
| Net income continuous operations | 1,714.55%40.66M | 2,590.42%11.52M | 56.31%7.01M | 13.53%16.6M | -77.20%9.84M | 107.27%2.24M | -49.94%428K | 212.99%4.48M | 103.99%14.62M | 125.50%43.18M |
| Net income discontinuous operations | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Noncontrolling interests | 305.20%4.38M | -1,228.07%-643K | 10.30%4.55M | 126.55%3.21M | 105.69%840K | -389.55%-2.13M | -96.66%57K | 1,641.35%4.13M | -125.90%-12.07M | -403.69%-14.75M |
| Net income attributable to the company | 729.37%36.29M | 3,177.09%12.16M | 591.27%2.45M | -49.82%13.4M | -84.46%9M | 113.86%4.38M | 143.44%371K | -70.29%355K | 107.38%26.69M | 134.82%57.93M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 729.37%36.29M | 3,177.09%12.16M | 591.27%2.45M | -49.82%13.4M | -84.46%9M | 113.86%4.38M | 143.44%371K | -70.29%355K | 107.38%26.69M | 134.82%57.93M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 730.36%0.0465 | 3,020.00%0.0156 | 520.00%0.0031 | -49.85%0.0171 | -84.50%0.0115 | 113.86%0.0056 | 145.45%0.0005 | -66.67%0.0005 | 107.37%0.0341 | 134.82%0.0742 |
| Diluted earnings per share | 745.28%0.0448 | 2,840.00%0.0147 | 480.00%0.0029 | -50.15%0.017 | -85.71%0.0106 | 113.12%0.0053 | 145.45%0.0005 | -66.67%0.0005 | 107.37%0.0341 | 134.82%0.0742 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.